Sort
30,917 grants matching “tumor microenvironment”
Host-tumor interactions and cancer relapse after radiation therapy
$316,438Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2016 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$316,438Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2020 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$316,438Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2021 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2018 · CA
Restoring anti-tumor immunity in the microenvironment of head and neck cancer
$316,438Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2016 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2017 · CA
Role of Foxm1 in Lung Cancer Microenvironment
$316,438Tanya Kalin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2010 · CA
Host-tumor interactions and cancer relapse after radiation therapy
$316,438Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2015 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2015 · CA
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
$316,438Erika L Pearce · Washington University · R01 · FY2014 · CA
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
$316,437Pankaj Kumar Singh · University Of Nebraska Medical Center · P01 · FY2020 · CA
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
$316,437Pankaj Kumar Singh · University Of Nebraska Medical Center · P01 · FY2021 · CA
Mechanism of Action of CpG-ODN in Generating Tumor Immunity in the Aged
$316,418Joseph Lustgarten · Mayo Clinic Arizona · R01 · FY2008 · AG
Mechanism of Action of CpG-ODN in Generating Tumor Immunity in the Aged
$316,418Joseph Lustgarten · Mayo Clinic Arizona · R01 · FY2009 · AG
Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma
$316,416Muller Fabbri · University Of Hawaii At Manoa · R01 · FY2020 · CA
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
$316,411Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
$316,405Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · CA
Project 3: Determining biomarkers for responsiveness to immunotherapy targeting LAG3/PD1 in HNSCC
$316,388Tullia Carmela Bruno · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Core B â Human Biospecimen and Advanced Sequencing Core
$316,362Leonidas G Koniaris · Medical University Of South Carolina · P01 · FY2022 · CA
Role of LRP in Astrocytoma Migration
$316,350University Of Virginia Charlottesville · R01 · FY2005 · NS
Role of LRP in Astrocytoma Migration
$316,350University Of Virginia Charlottesville · R01 · FY2004 · NS
High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics
$316,319Peter John Espenshade · Johns Hopkins University · R01 · FY2024 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$316,265Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2018 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,178David G Denardo · Washington University · R01 · FY2014 · CA